Healthcare >> CEO Interviews >> November 5, 2004
PHILIP GOULD joined Provalis PLC in January 1998 as Director of Research
and Development and became Chief Executive Officer in January 1999.
Prior to joining Provalis, he was head of new product introduction at
GlaxoWellcome. Before GlaxoWellcome, Dr. Gould worked at a number of
other pharmaceutical companies, including Reckitt & Colman
Pharmaceuticals, Pfizer Central Research and Lederle Laboratories. Dr.
Gould became a Fellow of the Royal Society of Chemistry in 1990. He has
a BSc University of Hull and has published widely on drug delivery
systems. He is also an Honorary Professor of Health Sciences at John
Moore's Liverpool University. Dr. Gould is also the inventor of four
patented pharmaceutical systems. Profile
Dr. Gould: Provalis is a small London and NASDAQ listed healthcare
company based in the northwest of the UK, with sales operations in the
UK, Ireland, and the States.
